Skip to content
EU Company Leads

NACE Rev. 2.1 · Group · Section C

21.1 Manufacture of basic pharmaceutical products

Level
Group
NACE Rev. 2
21.1
National codes
Same as NACE
Active companies
645

What 21.1 covers

Eurostat publishes no separate explanatory note for this group; its scope is the sum of the classes listed below.

Also searched as

  • pharma
  • pharmaceutical
  • biotech
  • biotechnologie
  • biotechnology
  • bioteknologia

Plain-language terms that lookup_industry maps to this code or the codes under it.

Classes in 21.1

National codes for 21.1

Every EU country uses NACE Rev. 2.1 as its national classification, sometimes with an extra national level. Sections, divisions and groups are identical in every national version; national detail only starts below the 4-digit class.

National classification codes corresponding to NACE 21.1
Country Classification Code Local title
France NAF 2025 INSEE 21.1 Identical to NACE at this level Fabrication de produits pharmaceutiques de base
Sweden SNI 2025 Statistics Sweden (SCB) 21.1 Identical to NACE at this level Tillverkning av farmaceutiska basprodukter
Belgium NACE-BEL 2025 Statbel 21.1 Identical to NACE at this level Vervaardiging van farmaceutische grondstoffen
Czech Republic CZ-NACE 2025 Czech Statistical Office (ČSÚ) 21.1 Identical to NACE at this level Výroba základních farmaceutických výrobků
Finland TOL 2025 Statistics Finland 21.1 Identical to NACE at this level Lääkeaineiden valmistus
Estonia EMTAK 2025 Statistics Estonia 21.1 Identical to NACE at this level Põhifarmaatsiatoodete tootmine

Local titles are the official NACE Rev. 2.1 translations; national tables can word them slightly differently. Belgium is shown with the Dutch title (French in the translations table).

21.1 in other EU languages

The official title of NACE 21.1 in each language version of NACE Rev. 2.1.

Official translations of the title
Language Title
French France (NAF), Belgium (NACE-BEL) Fabrication de produits pharmaceutiques de base
German Germany (WZ), Austria (ÖNACE) Herstellung von pharmazeutischen Grundstoffen
Swedish Sweden (SNI) Tillverkning av farmaceutiska basprodukter
Finnish Finland (TOL) Lääkeaineiden valmistus
Czech Czech Republic (CZ-NACE) Výroba základních farmaceutických výrobků
Estonian Estonia (EMTAK) Põhifarmaatsiatoodete tootmine
Dutch Belgium (NACE-BEL), Netherlands (SBI) Vervaardiging van farmaceutische grondstoffen
Danish Denmark (DB) Fremstilling af farmaceutiske råvarer
Spanish Spain (CNAE) Fabricación de productos farmacéuticos de base
Italian Italy (ATECO) Fabbricazione di prodotti farmaceutici di base
Polish Poland (PKD) Produkcja podstawowych substancji farmaceutycznych
Portuguese Portugal (CAE) Fabricação de produtos farmacêuticos de base

What changed from NACE Rev. 2

Unchanged from Rev. 2

NACE Rev. 2.1 replaced Rev. 2 in EU statistics from 2025, and national registers are recoding companies to it. These Rev. 2 codes map to 21.1, according to Eurostat’s official correspondence table:

  • Rev. 2 21.1 Manufacture of basic pharmaceutical products maps entirely here

Companies under 21.1

Active legal entities whose main activity is one of the 1 classes in 21.1, from the official business registers. Refreshed daily; sole traders are not included.

  • Belgium 356
  • France 226
  • Sweden 22
  • Finland 16
  • Estonia 14
  • Czech Republic 11

Total: 645. A dash means no companies with this main activity in the index yet.

Find 21.1 companies from Claude

EU Company Leads is an MCP server. Your agent resolves the industry with lookup_industry, then lists companies with search_companies, filtered by size, age, region and more.

1 · lookup_industry

{
    "query": "pharma"
}

2 · search_companies

{
    "nace_codes": [
        "21.1"
    ],
    "countries": [
        "BE",
        "FR"
    ],
    "limit": 25
}

Questions about NACE 21.1

What is NACE 21.1?

NACE 21.1 is the group “Manufacture of basic pharmaceutical products” in NACE Rev. 2.1, the EU statistical classification of economic activities, part of division 21 (Manufacture of basic pharmaceutical products and pharmaceutical preparations), in section C (Manufacturing).

What is the national equivalent of NACE 21.1 in France, Sweden, Belgium, Czech Republic, Finland and Estonia?

The national versions of NACE Rev. 2.1 keep sections, divisions and groups unchanged, so 21.1 is also 21.1 in NAF 2025 (France), SNI 2025 (Sweden), NACE-BEL 2025 (Belgium), CZ-NACE 2025 (Czech Republic), TOL 2025 (Finland) and EMTAK 2025 (Estonia). National detail is only added below the 4-digit class.

What was the NACE Rev. 2 code for NACE 21.1?

The code is unchanged: NACE Rev. 2 21.1 (Manufacture of basic pharmaceutical products) maps one-to-one to 21.1 in NACE Rev. 2.1.

How many companies are registered under NACE 21.1?

EU Company Leads holds 645 active companies whose main activity is 21.1: Belgium 356, France 226, Sweden 22, Finland 16, Estonia 14, Czech Republic 11. Counts come from the official business registers and are refreshed daily; sole traders are not included.

Other groups in 21

Headings, explanatory notes, translations and the Rev. 2 → Rev. 2.1 correspondence: © European Union, Eurostat, NACE Rev. 2.1, licensed under CC BY 4.0; formatted and linked by EU Company Leads. Company counts: official national business registers.

Get the full list in Claude, filtered your way.

Connect EU Company Leads over MCP and ask in plain language.

Request access